Search
Customer Support

Contact our support team if you have any enquiries about any of our products

Call: (856) 848-8698

Email: info@akersbio.com

Investor FAQs

When was your initial public offering?

We first went public on the London Stock Exchange’s AIM Market on May 22, 2002 at a U.S. equivalent price of $2.00 per share. On January 23, 2014 we also listed on the NASDAQ Capital Market at a price of $5.50 per share.

Have you had any stock splits?

Yes. On November 22, 2013, ahead of our listing on the NASDAQ Capital Market, we had a reverse split (consolidation) by which shareholders exchanged 156 common shares for 1 new consolidated common share of no par value.

On which exchanges are your shares traded?

Our shares are traded on both the NASDAQ Capital Market and the London Stock Exchange’s AIM Market.

What are the ticker symbols?

NASDAQ: AKER

AIM: AKR

Who are your transfer agents?

Can I transfer my stock between exchanges?

Yes. If you originally purchased stock on the London Stock Exchange and want to transfer to NASDAQ, click here to obtain a transfer form (please contact Capita Asset Services if you have any questions regarding the process of the completion of this transfer form). If you want to transfer stock from NASDAQ to the London Stock Exchange, click here to obtain a transfer form (please contact VStock Transfer if you have any questions regarding the process of the completion of this transfer form). Akers Bio does not administer the transfer process and fees may be payable to the transfer agents.

I would like to buy shares in Akers Biosciences, Inc. Can I make direct purchases from the company?

No, we don’t operate a direct purchase program. However, our shares are traded on both the NASDAQ Capital Market and the London Stock Exchange’s AIM Market – shares can be bought through a stockbroker or normal share dealing platforms and services.

What should I do if my stock certificates are lost or stolen?

For inquiries regarding lost or stolen stock certificates contact Capita Asset Services regarding UK certificates or VStock Transfer regarding US certificates.

Where are you incorporated?

Akers Biosciences, Inc. is incorporated in the United States which is also our main country of operation. Our headquarters are in Thorofare, New Jersey.

When is your fiscal year end?

Our fiscal year end is December 31.

How do I contact your investor relations team?

Email us your inquiry to investors@akersbio.com and the appropriate member of our investor relations team will get back to you as soon as possible.